154 related articles for article (PubMed ID: 29231256)
1. Chemotherapy-induced eccrine squamous syringometaplasia in an infant.
Bittar PG; Casady M; Selim MA; Prose NS
Pediatr Dermatol; 2018 Jan; 35(1):e84-e85. PubMed ID: 29231256
[TBL] [Abstract][Full Text] [Related]
2. Imatinib-induced eccrine squamous syringometaplasia.
Van de Voorde K; De Raeve H; Van Regenmortel N; Lambert J
J Am Acad Dermatol; 2006 Aug; 55(2 Suppl):S58-9. PubMed ID: 16843129
[No Abstract] [Full Text] [Related]
3. Chemotherapy-induced eccrine squamous syringometaplasia. A distinctive eruption in patients receiving hematopoietic progenitor cells.
Valks R; Fraga J; Porras-Luque J; Figuera A; Garcia-Diéz A; Fernändez-Herrera J
Arch Dermatol; 1997 Jul; 133(7):873-8. PubMed ID: 9236526
[TBL] [Abstract][Full Text] [Related]
4. [Eccrine squamous syringometaplasia from chemotherapy extravasation].
Bordel MT; Miranda A
Actas Dermosifiliogr; 2005 Sep; 96(7):462-4. PubMed ID: 16476276
[TBL] [Abstract][Full Text] [Related]
5. Eccrine squamous syringometaplasia secondary to cutaneous extravasation of docetaxel: report of three cases.
Gallo E; Llamas-Velasco M; Navarro R; Fraga J; García-Diez A
J Cutan Pathol; 2013 Mar; 40(3):326-9. PubMed ID: 23170995
[TBL] [Abstract][Full Text] [Related]
6. Eccrine squamous syringometaplasia and syringomatous hyperplasia in association with linear scleroderma.
Sakai H; Satoh K; Manabe A; Nakane H; Ishida-Yamamoto A; Iizuka H
Dermatology; 2002; 204(2):136-8. PubMed ID: 11937740
[TBL] [Abstract][Full Text] [Related]
7. Syringometaplasia: mucinous and squamous variants.
King DT; Barr RJ
J Cutan Pathol; 1979 Aug; 6(4):284-91. PubMed ID: 500875
[TBL] [Abstract][Full Text] [Related]
8. Olanzapine-induced eccrine squamous syringometaplasia.
Molina-Ruiz AM; Molina-Ruiz RM; Zulueta T; Barabash R; Requena L
Am J Dermatopathol; 2012 Jun; 34(4):434-7. PubMed ID: 22257902
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen-induced eccrine squamous syringometaplasia.
Teoh DC; Aw DC; Jaffar H; Ling W; Yong WP; Lee YS; Choo SN; Tan KB
J Cutan Pathol; 2012 May; 39(5):554-7. PubMed ID: 22390276
[TBL] [Abstract][Full Text] [Related]
10. Eccrine squamous syringometaplasia associated with dabrafenib therapy.
Liuti F; Martín PA; Montenegro Damaso T; Abreu DR; Santana JH
J Am Acad Dermatol; 2013 Nov; 69(5):e273-e274. PubMed ID: 24124864
[No Abstract] [Full Text] [Related]
11. Vemurafenib-induced eccrine squamous syringometaplasia.
Lescoat A; Droitcourt C; Stock N; Le Gall F; Dupuy A
Dermatology; 2013; 226(4):362-4. PubMed ID: 23860306
[TBL] [Abstract][Full Text] [Related]
12. [Eccrine squamous syringometaplasia and cytomegalovirus infection].
Baysse L; Boralevi F; Lepreux S; Boyer A; Morel C; Léauté-Labrèze C; Taïeb A
Rev Med Interne; 2003 Jun; 24(6):394-8. PubMed ID: 12814829
[TBL] [Abstract][Full Text] [Related]
13. Leukemia cutis and eccrine squamous syringometaplasia.
Bouceiro-Mendes R; Antunes-Duarte S; Aguado-Lobo M; Espinosa-Lara P; Soares-de-Almeida L; Filipe P
Dermatol Online J; 2021 Jun; 27(6):. PubMed ID: 34387058
[TBL] [Abstract][Full Text] [Related]
14. Ciliated and Mucinous Adenomatous Syringometaplasia: The Missing Link of the "Ciliated Eccrine Metaplasia" Theory in the Histogenesis of Cutaneous Eccrine Ciliated Cyst?
Tran TAN
Am J Dermatopathol; 2021 Nov; 43(11):827-830. PubMed ID: 33606368
[TBL] [Abstract][Full Text] [Related]
15. Squamous syringometaplasia in association with annular elastolytic granuloma.
Helton JL; Metcalf JS
Am J Dermatopathol; 1995 Aug; 17(4):407-9. PubMed ID: 8600809
[TBL] [Abstract][Full Text] [Related]
16. Eccrine squamous syringometaplasia in intertriginous areas.
Valks R; Buezo GF; Daudén E; Fraga J; García-Díez A
Br J Dermatol; 1996 May; 134(5):984-6. PubMed ID: 8736357
[No Abstract] [Full Text] [Related]
17. Eccrine squamous syringometaplasia and cytomegalovirus.
Daudén E; Porras JI; Buezo GF; García-Díez A
Am J Dermatopathol; 2000 Dec; 22(6):559-61. PubMed ID: 11190451
[No Abstract] [Full Text] [Related]
18. Eccrine squamous syringometaplasia in sites of radiation recall secondary to vemurafenib therapy for BRAF-mutated carcinoma.
Moioli EK; Ligtenberg KG; Kenkare S; Shea CR; Soltani K
J Dermatol; 2016 Oct; 43(10):1233-1234. PubMed ID: 27094584
[No Abstract] [Full Text] [Related]
19. Eccrine squamous syringometaplasia in the skin of children after burns.
Sommer B; Hagedorn M; Wood F; Heenan P
J Cutan Pathol; 1998 Jan; 25(1):56-8. PubMed ID: 9508345
[TBL] [Abstract][Full Text] [Related]
20. Eccrine squamous syringometaplasia associated with vemurafenib therapy.
Story SG; Beschloss JK; Dolan CK; Thomas BC
J Am Acad Dermatol; 2012 Nov; 67(5):e208-10. PubMed ID: 23062917
[No Abstract] [Full Text] [Related]
[Next] [New Search]
